Evidence map›Paper›PMID 37175668›Full record

ArticleInternational journal of molecular sciences2023

Development of Erf-Mediated Craniosynostosis and Pharmacological Amelioration.

Angeliki Vogiatzi, Kleoniki Keklikoglou, Konstantinos Makris, Dionysia Stamatia Argyrou, Athanasios Zacharopoulos, Varvara Sotiropoulou, Nikolaos Parthenios, Angelos Gkikas, Maria Kokkori, Melodie S W Richardson and 9 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Angeliki VogiatziMedical School, University of Crete, 71003 Heraklion, Crete, Greece.
Kleoniki KeklikoglouInstitute of Marine Biology, Biotechnology and Aquaculture (IMBBC), Hellenic Centre for Marine Research (HCMR), P.O. Box 2214, 71003 Heraklion, Crete, Greece.ORCID 0000-0002-6693-2033
Konstantinos MakrisMedical School, University of Crete, 71003 Heraklion, Crete, Greece.ORCID 0000-0002-9404-5706
Dionysia Stamatia ArgyrouMedical School, University of Crete, 71003 Heraklion, Crete, Greece.
Athanasios ZacharopoulosIESL, FORTH, 71003 Heraklion, Crete, Greece.ORCID 0000-0003-3700-6898
Varvara SotiropoulouIESL, FORTH, 71003 Heraklion, Crete, Greece.
Nikolaos PartheniosICE-HT, FORTH, 26504 Patras, Peloponissos, Greece.ORCID 0000-0001-9204-0162
Angelos GkikasMedical School, University of Crete, 71003 Heraklion, Crete, Greece.
Maria KokkoriMedical School, University of Crete, 71003 Heraklion, Crete, Greece.
Melodie S W RichardsonDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, Mansfield Road, Oxford OX1 3TA, UK.
Aimée L FenwickMRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.ORCID 0000-0003-0279-1814
Sofia ArchontidiMedical School, University of Crete, 71003 Heraklion, Crete, Greece.
Christos ArvanitidisInstitute of Marine Biology, Biotechnology and Aquaculture (IMBBC), Hellenic Centre for Marine Research (HCMR), P.O. Box 2214, 71003 Heraklion, Crete, Greece.
Jeremy RobertsonDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, Mansfield Road, Oxford OX1 3TA, UK.ORCID 0000-0002-6809-8265
John PartheniosICE-HT, FORTH, 26504 Patras, Peloponissos, Greece.ORCID 0000-0001-6066-7120
Giannis ZacharakisIESL, FORTH, 71003 Heraklion, Crete, Greece.
Stephen R F TwiggMRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
Andrew O M WilkieMRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
George MavrothalassitisMedical School, University of Crete, 71003 Heraklion, Crete, Greece.
University of Crete · GRUniversity of Oxford · GBFORTH Institute of Electronic Structure and Laser · GRFORTH Institute of Chemical Engineering Sciences · GRHellenic Centre for Marine Research · GR

Funding

Medical Research Council G0902418Wellcome Trust 102731/Z/13/Z
6 · The paper itself

Abstract

ETS2 repressor factor (

Indexed as

CraniosynostosesTranscription FactorsAnimalsMAP Kinase Signaling SystemMicePhosphorylationRepressor ProteinsSkullErf protein, mouseRepressor ProteinsTranscription FactorscraniosynostosisEts2 repressor factorpharmacological modulation

Identifiers

PMID37175668
PMCPMC10178537
OpenAlexW4367317237

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.